SG25093G - Novel fusion protein - Google Patents

Novel fusion protein

Info

Publication number
SG25093G
SG25093G SG250/93A SG25093A SG25093G SG 25093 G SG25093 G SG 25093G SG 250/93 A SG250/93 A SG 250/93A SG 25093 A SG25093 A SG 25093A SG 25093 G SG25093 G SG 25093G
Authority
SG
Singapore
Prior art keywords
gst
enzyme
fusion protein
peptide
fused
Prior art date
Application number
SG250/93A
Other languages
English (en)
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Publication of SG25093G publication Critical patent/SG25093G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088Glutathione transferase (2.5.1.18)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG250/93A 1987-05-28 1993-03-06 Novel fusion protein SG25093G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI219587 1987-05-28

Publications (1)

Publication Number Publication Date
SG25093G true SG25093G (en) 1993-06-11

Family

ID=3772204

Family Applications (1)

Application Number Title Priority Date Filing Date
SG250/93A SG25093G (en) 1987-05-28 1993-03-06 Novel fusion protein

Country Status (14)

Country Link
EP (1) EP0293249B1 (ja)
JP (1) JPH0681596B2 (ja)
AT (1) ATE79902T1 (ja)
AU (1) AU607511B2 (ja)
CA (1) CA1338903C (ja)
DE (1) DE3873989T2 (ja)
DK (1) DK169975B1 (ja)
ES (1) ES2045115T3 (ja)
GR (1) GR3006173T3 (ja)
NO (1) NO178894C (ja)
NZ (1) NZ224663A (ja)
SG (1) SG25093G (ja)
WO (1) WO1988009372A1 (ja)
ZA (1) ZA883681B (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008819A1 (en) * 1989-01-31 1990-08-09 Daratech Pty. Ltd. Vaccine for the preventative treatment of infection of liver fluke in ruminants
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
FR2657883A1 (ja) * 1990-02-07 1991-08-09 Transgene Sa
US6077694A (en) * 1990-09-21 2000-06-20 The United States Of America As Represented By The Department Of Health And Human Services Method for over-expression and rapid purification of biosynthetic proteins
WO1993003157A1 (en) * 1991-07-29 1993-02-18 Dana Farber Cancer Institute Plasmids for the rapid preparation of modified proteins
US6372249B1 (en) 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
US5596079A (en) * 1991-12-16 1997-01-21 Smith; James R. Mimetics of senescent cell derived inhibitors of DNA synthesis
CA2132321A1 (en) * 1992-03-18 1993-09-30 Donald B. Smith Tripartite fusion proteins of glutathione s-transferase
GB9210337D0 (en) * 1992-05-14 1992-07-01 Univ Court Of The University O Feline leukaemia virus vaccine
AU6172194A (en) * 1993-02-08 1994-08-29 Paravax, Inc. Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens
US5532142A (en) * 1993-02-12 1996-07-02 Board Of Regents, The University Of Texas System Method of isolation and purification of fusion polypeptides
US5480864A (en) * 1993-08-06 1996-01-02 Shiseido Co., Ltd. Modified maxadilan protein, its preparation and use, and DNA encoding the protein
JP3822232B2 (ja) * 1993-08-30 2006-09-13 ベイラー・カレッジ・オブ・メディシン 老化細胞由来dna合成阻害因子
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
GB9502489D0 (en) * 1995-02-09 1995-03-29 Animal Health Trust Expression of the non-structural protein NS1 of influenza virus and detection of anti-NS1 antibody in serum
US5800811A (en) * 1995-06-06 1998-09-01 Hall; Frederick L. Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
SG49993A1 (en) 1995-12-28 1998-06-15 Fujirebio Kk Fused dna sequence fused protein expressed from said fused dna sequence and method for expressing said fused protein
DE19653498C1 (de) * 1996-12-20 1998-07-23 Wolf M Prof Dr Bertling Klonierungsvektor-System mit Fusionssequenz
DE69842048D1 (de) 1997-08-01 2011-01-27 Max Planck Gesellschaft Zusammensetzung und verfahren zum nachweis von krankheiten in zusammenhang mit der bildung von amyloid-ähnlichen fibrillen oder protein-aggregaten
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6077689A (en) * 1997-12-24 2000-06-20 Amgen Inc. Enhanced solubility of recombinant proteins
US6187558B1 (en) 1998-06-24 2001-02-13 Boyce Thompson Institute For Plant Research, Inc. Invertebrate intestinal mucin cDNA and related products and methods
AU4710899A (en) * 1998-06-24 2000-01-10 Boyce Thompson Institute For Plant Research Inc. A novel invertebrate intestinal mucin cdna and related products and methods
US7595199B1 (en) 1998-07-31 2009-09-29 Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. Method of detecting amyloid-like fibrils or protein aggregates
GB9821821D0 (en) * 1998-10-07 1998-12-02 Univ Wales Schistomiasis vaccine
US7063837B2 (en) 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
US6632638B1 (en) 2000-11-17 2003-10-14 Amgen, Inc. Enhanced solubility of recombinant proteins using Uracil DNA glycosylase inhibitor
MXPA03011455A (es) 2001-06-22 2004-04-05 Hoffmann La Roche Complejo soluble que comprende glucoproteina de superficie retroviral.
US6962982B2 (en) 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
US7094757B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
ES2255347B1 (es) * 2003-05-21 2007-05-16 Universidad De Vigo Proteina de fusion gst-fucosidasa con actividad enzimatica alfa-l-fucosidasica. proteina recombinante alfa-l-fucosidasa humana.
MY160430A (en) * 2008-12-12 2017-03-15 Univ Sains Malaysia Recombinant antigen for detection of toxocariasis
GB0823550D0 (en) 2008-12-24 2009-01-28 Kinasource Ltd Peptide tag and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3036684A (en) * 1983-07-07 1985-01-10 Genex Corp. Production of bovine calf chymosin
MA20977A1 (fr) * 1986-05-19 1987-12-31 Ciba Geigy Ag Plantes tolerant les herbicides contenant le gene de gluthathione S-Transferase
AU613583B2 (en) * 1986-08-22 1991-08-08 Transgene S.A. Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
AU603145B2 (en) * 1986-10-14 1990-11-08 Shionogi & Co., Ltd. Aminoglycoside phosphotransferase-proteinfusions

Also Published As

Publication number Publication date
AU1793288A (en) 1988-12-21
GR3006173T3 (ja) 1993-06-21
DK38189A (da) 1989-01-27
NO890325D0 (no) 1989-01-26
DK169975B1 (da) 1995-04-18
EP0293249A1 (en) 1988-11-30
NO178894B (no) 1996-03-18
DE3873989D1 (de) 1992-10-01
CA1338903C (en) 1997-02-11
DE3873989T2 (de) 1993-02-04
JPH0681596B2 (ja) 1994-10-19
NO890325L (no) 1989-03-06
ZA883681B (en) 1989-07-26
AU607511B2 (en) 1991-03-07
ATE79902T1 (de) 1992-09-15
DK38189D0 (da) 1989-01-27
WO1988009372A1 (en) 1988-12-01
ES2045115T3 (es) 1994-01-16
NO178894C (no) 1996-06-26
JPH01503441A (ja) 1989-11-22
NZ224663A (en) 1990-11-27
EP0293249B1 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
SG25093G (en) Novel fusion protein
Brown et al. Structural modifications associated with the change in Ca2+ sensitivity on activation of m‐calpain
DK161290A (da) Muterede subtilisingener
Nakajima et al. Chemical modification of earthworm fibrinolytic enzyme with human serum albumin fragment and characterization of the protease as a therapeutic enzyme
GB2160206B (en) Dna sequence coding for an enzyme cleavage site
HUT43634A (en) Process for expressing vii and ix factor-activity in mammalian celles
DE3650540T2 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
AU1283288A (en) Production and purification of a protein fused to a binding protein
CA2202639A1 (fr) Proteines recombinantes de l'hemagglutinine filamenteuse de bordetella, notamment bordetella pertussis, procede pour leur production et leurs applications a la production de proteines etrangeres ou de principes actifs vaccinants
WO1988005081A3 (en) Novel plasminogen activator
DK315582A (da) T4 dna-fragment som stabilisator for proteiner udtrykt ved klonet dna
Kalafatis et al. [13] Factor V
NO307384B1 (no) Fremgangsmåte for spalting av proteiner og anvendelse av denne
ATE142263T1 (de) Verfahren zur herstellung von fremdproteinen in streptomyceten
Iemura et al. Properties of TCA-insoluble peptides in kimoto (traditional seed mash for sake brewing) and conditions for liberation of the peptides from rice protein